Public COA audit
CJC-1295 (No DAC)/Ipamorelin
Audited September 5, 2026
Document structure and test panels align with what we expect from authentic lab reports.
- Legitimacy
- 92
- Confidence
- 95%
- Panels
- 1/7
Scored high because document structure and panels look consistent with authentic lab output and limited panel coverage (1/7). To improve: include identity, purity, and endotoxin at minimum.
Document details
Fields extracted from the certificate — not order or payment data.
- Batch / lot
- CJIP202602
- Sample date
- 2026-02-25
- Issue date
- 2026-02-25
Original certificate
Embedded copy of the stored COA PDF or image. Download it for your records — PeptIQ’s audit is separate from the lab document itself.
7-panel checklist
Had data + good, had data + bad, reported without pass/fail, or missing. Missing lowers thoroughness — you decide whether that panel matters; PeptIQ’s score still factors coverage.
1 of 7 present · 1 passed · 0 failed · 0 reported · 6 missing
Missing is a thoroughness gap — not automatically bad. PeptIQ’s legitimacy score still weighs panel coverage; you can down-weight panels that don’t matter for your use case.
Identity
Not on this certificate file · core
Compound identity confirmed (e.g. HPLC, mass spec).
No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”
Purity
Not on this certificate file · core
Reported purity percentage for the analyte.
No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”
Heavy metals
Not on this certificate file
Lead, arsenic, cadmium, mercury, or similar limits.
No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”
Microbial
Not on this certificate file
Bioburden / microbial limits testing.
No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”
Endotoxin
Tested · passed · core
LAL or chromogenic endotoxin assay.
< 0.05 EU/mL
Sterility
Not on this certificate file
Sterility testing where applicable.
No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”
Residual solvent / water
Not on this certificate file
Residual solvents or water content limits.
No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”
How to read this
Had data · good
Panel present with a pass (or clear acceptance).
Had data · bad
Panel present with a fail — a concrete quality signal.
Had data · unclear
Value reported without an explicit pass/fail mark.
Missing on this file
Not on this certificate file. Lowers file thoroughness; a sibling endotoxin/purity report for the same lot may still exist. PeptIQ’s score still factors coverage.
Findings
Evidence-linked observations from this audit.
Endotoxin-specific report
This is a dedicated bacterial endotoxin analysis report from Kovera Labs. It is scoped specifically to endotoxin testing and does not include purity, identity, or other panels. This is a common practice for split testing where different assays are reported separately.
Comprehensive endotoxin methodology
Complete USP <85> kinetic chromogenic LAL assay with detailed methodology, controls (positive/negative both passed), spike recovery (84%), and CV values (4.2% sample, 4.7% spike). Result < 0.05 EU/mL well below acceptance limit of ≤ 0.5 EU/mL.
Professional lab presentation
Kovera Labs report with verification URL (koveralabs.com/verify), sample ID KVR-2026-807832, access code 3CFFE7, and dual authorization by QC Analyst (Liam Clarke, B.S.) and Quality Director (David Cohen, M.S.).
Clear batch identification
Lot/Batch CJIP202602 clearly stated for CJC-1295 (No DAC)/Ipamorelin blend, 20 mg strength, lyophilized condition.
Current test date
Test date 2026-02-25 is valid and within normal timeframe relative to current date 2026-09-05.
Professional document structure
Well-organized report with clear sections for client information, methodology, quantitative results, controls, interpretation, and authorization. Includes QR code for verification.
PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.